Omalizumab linked to decreased healthcare use for “tough to treat” allergic asthma│ERS

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway 

  • Omalizumab treatment for uncontrolled persistent allergic asthma is associated with a significant decrease in the number of hospitalizations, ER visits, and oral corticosteroid use in Canadian patients seen in clinical practice. 

Why this matters 

  • In Canada, asthma is the leadi...